Home > Insider Trading > Filing (0001012975-14-000555)

Filing Details

Accession Number:: 0001012975-14-000555
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-11 17:34:46
Reporting Period:: 2014-09-09

Filing Date:: 2014-09-11
Accepted Time:: 2014-09-11 17:34:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231092	James Niedel	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-09-09	217,321	$28.72	1,326,073	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-09-09	58,531	$29.67	1,267,542	No	4	S	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-09	200,879	$7.26	1,468,421	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2014-09-09	51,100	$28.54	1,417,321	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-09-10	347,188	$29.54	1,070,133	No	4	S	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-10	401,758	$7.26	1,471,891	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2014-09-10	97,129	$30.03	1,374,762	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-09-11	328,680	$29.58	1,046,082	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Disposition	2014-09-09	200,879	$0.00	200,879	$7.26
Common Stock	Warrant	Disposition	2014-09-10	401,758	$0.00	401,758	$7.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
401,758		2018-02-07	No	4	X	Indirect
0		2018-02-07	No	4	X	Indirect

Footnotes

The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $28.50 to $29.49, inclusive. The Reporting Person undertakes to provide to CMRX, any security holder of CMRX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, 5 and 7.
The securities are directly held by New Leaf Ventures II, L.P. ("NLV II") and indirectly held by New Leaf Venture Associates II, L.P. ("NLV Associates"), the sole general partner of NLV II, and New Leaf Venture Management II, L.L.C. ("NLV Management"), the sole general partner of NLV Associates. As an individual manager of NLV Management, along with five other individual managers, the Reporting Person may be deemed to beneficially own the shares to which this Form 4 relate. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $29.50 to $29.73, inclusive.
On September 9, 2014, NLV II exercised warrants to purchase 200,879 shares of CMRX common stock for $7.26 a share. NLV II paid the exercise price on a cashless basis, resulting in CMRX's withholding of 51,100of the warrant shares to pay the exercise price and issuing to NLV II the remaining 147,779 shares.
The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $29.16 to $30.03, inclusive.
On September 10, 2014, NLV II exercised warrants to purchase 401,758 shares of CMRX common stock for $7.26 a share. NLV II paid the exercise price on a cashless basis, resulting in CMRX's withholding of 97,129 of the warrant shares to pay the exercise price and issuing to NLV II the remaining 304,629 shares.
The price reported in Column 4 is a weighted average price (net of commissions of $0.04 per share). These shares were sold in multiple transactions at prices ranging from $29.50 to $30.43, inclusive.
The Warrants are immediately exercisable.